发明授权
- 专利标题： BLOOD STAGE MALARIA VACCINE
- 专利标题（中）： 疟疾疫苗在血液体育场
-
申请号： EP12793152.5申请日： 2012-05-28
-
公开(公告)号： EP2714075B1公开(公告)日： 2016-11-16
- 发明人: LEE, Moses , GOOD, Michael , SPITHILL, Terry
- 申请人： Griffith University , La Trobe University , Lee, Moses
- 申请人地址： 170 Kessels Road Nathan, Queensland 4111 AU
- 专利权人： Griffith University,La Trobe University,Lee, Moses
- 当前专利权人： Griffith University,La Trobe University,Lee, Moses
- 当前专利权人地址： 170 Kessels Road Nathan, Queensland 4111 AU
- 代理机构： Hylarides, Paul Jacques
- 优先权： US201161490761P 20110527; NL2007292 20110823; US201261617435P 20120329
- 国际公布： WO2012162731 20121206
- 主分类号： A61K39/015
- IPC分类号： A61K39/015 ; A61P33/06
摘要：
An immunogenic composition for use as a blood-stage malaria vaccine, a method of producing the immunogenic composition and a method of treatment of malaria are provided. The immunogenic composition includes isolated or purified merozoites, or red blood cells infected with merozoites, treated with centanamycin or tafuramycin A. The immunogenic composition does not include an adjuvant. A single dose of the immunogenic composition is sufficient to protect an animal against subsequent malaria infection by the same isolate, strain or species of Plasmodium used in the immunogenic composition, or by one or more heterologous isolates, strains or species of Plasmodium.
公开/授权文献
- EP2714075A1 BLOOD STAGE MALARIA VACCINE 公开/授权日：2014-04-09
信息查询
